The Real Cost of Not Drug Testing: Workplace Accidents, Liability, and Turnover

‍

Medically Reviewed by the Clinical Team at MD Diagnostics

CLIA-Certified Laboratory

‍

The decision not to implement a workplace drug testing program is often framed as a cost-saving measure. No testing program means no cost per test, no administrative overhead, and no time spent managing the process. On paper, it looks like an easy way to reduce operational spending.

‍

The reality is different. The absence of a workplace drug testing program does not eliminate risk. It transfers it, from the testing process to your workplace, your liability exposure, your workforce, and ultimately your bottom line.

‍

This article examines what that risk actually looks like in measurable terms, and why the cost of not testing consistently exceeds the cost of testing for most employers.

‍

The Safety Risk Is Larger Than Most Employers Realize

‍

Substance use in the workplace is not a rare or fringe issue. Research from the National Safety Council estimates that employees with substance use disorders miss significantly more workdays than their peers, are involved in workplace accidents at higher rates, and are more likely to file workers' compensation claims.

‍

The U.S. Department of Labor has reported that approximately 70 percent of people who use illicit drugs are employed, meaning the workforce is the primary population where substance use intersects with safety risk. Industries with elevated physical hazard exposure, including construction, transportation, manufacturing, and healthcare, face compounded risks when impaired workers operate heavy equipment, drive commercial vehicles, handle medications, or work in safety-sensitive roles.

‍

The data on workplace accidents is consistent:

‍

• Workers with substance use disorders are 3.6 times more likely to be involved in a workplace accident than those without, according to research published in the Journal of Occupational and Environmental Medicine
• Drug and alcohol use is estimated to be a contributing factor in 10 to 20 percent of workplace fatalities
• Impaired employees are 5 times more likely to file a workers' compensation claim

‍

These are not theoretical risks. They represent costs that materialize as workers' compensation claims, OSHA investigations, operational shutdowns, lost productivity, and, in the most severe cases, lawsuits.

‍

The Liability Exposure That Follows an Incident

‍

When a workplace accident occurs and substance impairment is later identified as a contributing factor, the legal and regulatory consequences for an employer can be significant, particularly if the employer had no drug testing program in place and cannot demonstrate reasonable precautions were taken.

‍

Employers may face exposure across several dimensions:

‍

• Negligent hiring and retention: In many jurisdictions, employers have a duty to take reasonable steps to ensure their workforce does not pose an unreasonable risk to coworkers, customers, or the public. An employer who was aware of, or should have been aware of, substance use issues and took no action may face negligent retention claims.
• Workers' compensation complications: Many state workers' compensation systems allow employers to contest claims or reduce benefits paid when employee intoxication was a contributing cause of the injury. However, this defense is only available if the employer has a qualifying drug-free workplace program with appropriate testing in place. Without testing, the employer loses this option entirely.
• Third-party liability: If an impaired employee injures a customer, vendor, or member of the public in the course of employment, the employer may be exposed to direct tort liability. Trucking and transportation companies face this risk acutely.
• Regulatory action: For industries subject to Department of Transportation (DOT) regulations or other federal oversight, failure to implement required drug testing programs can result in fines, operational suspensions, and disqualification from federal contracts.

‍

The cost of defending any one of these claims typically exceeds a year's worth of drug testing program costs.

‍

The Turnover and Productivity Costs Are Ongoing

‍

Beyond safety incidents and legal exposure, substance use in the workplace creates ongoing operational costs that rarely appear in a single line item but accumulate steadily over time.

‍

The most significant of these is turnover. Employees with substance use disorders leave jobs at higher rates, whether voluntarily, through termination, or due to incapacity. The cost of replacing a single employee, accounting for recruiting, onboarding, training, and productivity loss during the transition, is commonly estimated at 50 to 200 percent of that employee's annual salary depending on role complexity.

‍

Additional ongoing costs include:

‍

• Absenteeism: Employees with substance use disorders miss an average of 14.8 days per year compared to 10.5 days for other employees, according to the Substance Abuse and Mental Health Services Administration (SAMHSA). In a workforce of 50 employees, even a small number of affected individuals creates meaningful lost productivity.
• Presenteeism: Employees who come to work impaired, or who are experiencing the effects of substance use without being acutely impaired, perform at reduced capacity. This cost is rarely tracked but consistently significant.
• Theft and dishonesty: Research consistently links substance use disorders with elevated rates of workplace theft, which compounds both financial and operational costs.

‍

What a Drug Testing Program Actually Costs

‍

To evaluate whether the cost of not testing makes sense, it helps to look at what a properly administered drug testing program actually costs per employee.

‍

Standard urine drug screening for employers typically ranges from $30 to $60 per test depending on the panel, the collection method, and the laboratory used. For a workforce of 50 employees, annual pre-employment and random testing at industry-standard rates might total $5,000 to $15,000 per year when all program components are accounted for.

‍

Compared to the cost of a single workers' compensation claim, which averages over $40,000 in the United States according to the National Council on Compensation Insurance, a single prevented incident covers years of testing program costs.

‍

The comparison becomes even clearer when third-party liability claims, regulatory penalties, or turnover-related costs are included.

‍

The Deterrence Effect That Does Not Show Up in Any Budget Line

‍

One of the most consistently documented benefits of workplace drug testing programs is deterrence, the measurable reduction in substance use among employees who know they are subject to testing.

‍

Research consistently shows that employees in workplaces with drug testing programs use substances at lower rates than those in untested workplaces. This effect is particularly strong in safety-sensitive industries. The deterrence benefit is not captured in any claim that was filed, any accident that occurred, or any turnover event that happened. It shows up only as the absence of costs that would have otherwise materialized.

‍

This makes it difficult to quantify directly, but the research base supporting it is substantial and consistent across decades of occupational health literature.

‍

Frequently Asked Questions

‍

Is workplace drug testing required by law?

‍

It depends on the industry and role. Employers regulated by the Department of Transportation, including those in trucking, aviation, rail, and other safety-sensitive sectors, are required to implement drug testing programs meeting federal standards. Other industries are generally not federally required to test, but many states offer incentives, including workers' compensation premium discounts, for certified drug-free workplace programs. 

Reviewing your state's specific programs is a practical starting point.

‍

What type of drug testing program is most effective?

‍

Programs that combine pre-employment screening with random and reasonable suspicion testing consistently outperform pre-employment-only programs. Employees who pass a pre-employment test may begin using substances after hire. Ongoing random testing maintains deterrence and identifies post-hire issues. Many programs also include post-accident testing and return-to-duty testing protocols.

‍

Can we be held liable for an impaired employee even without prior knowledge?

‍

In many cases, yes. Negligent retention claims do not always require that an employer had direct knowledge of substance use. If a court determines that a reasonable employer exercising appropriate oversight should have known, liability may still attach. A documented drug testing program demonstrates that reasonable steps were taken to manage the risk.

‍

What is a Medical Review Officer (MRO) and do we need one?

‍

A Medical Review Officer is a licensed physician trained to review and interpret drug test results, including evaluating legitimate medical explanations for positive results such as prescribed medications. For federally mandated drug testing programs, MRO review is required. For non-mandated employer programs, MRO review is strongly recommended to protect both the employer and the employee from acting on a result that may have a legitimate medical explanation.

‍

Does testing work for on-site employees at multiple locations?

‍

Yes. Mobile collection services and on-site testing options allow employers with distributed workforces or multiple locations to test consistently without requiring employees to travel to a fixed collection site. On-site and mobile testing options also reduce the window between identification of reasonable suspicion and collection, which matters for maintaining the integrity of the result.

‍

Conclusion

‍

The decision about whether to implement a workplace drug testing program is, at its core, a risk management decision. The costs of testing are visible, predictable, and manageable. The costs of not testing are invisible until they are not, and by then they typically arrive in the form of accidents, legal exposure, regulatory action, and workforce instability that far exceed what testing would have cost.

‍

For most employers, the question is not whether to implement a drug testing program but how to implement one that is legally defensible, operationally practical, and appropriate for their workforce and industry.

‍

MD Diagnostics provides comprehensive workplace drug testing services for employers throughout the St. Louis region, including pre-employment, random, reasonable suspicion, and post-accident testing. Contact our team to discuss how to build a program that fits your organization.

‍

This article is for informational purposes only and does not constitute medical advice. Always consult with your healthcare provider about your specific health concerns and lab results. MD Diagnostics is a CLIA-certified laboratory providing diagnostic testing services in the St. Louis region.

‍